Considering that lung cancer consists of heterogeneous tumors carrying distinct targetable driver gene mutations such as KRAS, EGFR, ALK, umbrella study can be perfectly implemented for lung cancer studies to explore the efficacy of different targeted drugs for patients with lung cancer. The gene discussed is ALK; the disease is lung cancer.